National Association for the Self-Employed (NASE) Growth Grants

The Office of Research Infrastructure Programs (ORIP) encourages grant applications aimed at developing, characterizing, or improving research models of human health and diseases; developing biology based new approach methodologies (NAMs) applicable to human health and diseases; or improving access to information about or generated from the use of models of human disease. The models, including NAMs, and related biological materials developed must be broadly applicable to the scientific interests of two or more NIH Institutes or Centers (ICs) and must evaluate diseases and processes that impact multiple organ systems in order to align with the ORIP"s NIH-wide mission and programs. Applications must describe the need for and the potential impact of the proposed resources on the research community across a range of scientific disciplines supported by multiple NIH ICs. Applications to develop models that relate strictly to a specific disease or a select area of research or that do not have a broad impact on the NIH-wide research community will not be accepted. Projects that predominantly address the research interests of one NIH IC but are only peripherally related to the research interests of other ICs will also not be accepted, if submitted in response to this notice of funding opportunity (NOFO).

Every year, Cartier awards three grants to women-owned businesses in nine different regions around the world. The Cartier Women’s Initiative Awards program is designed to support early-stage businesses that are focused on a range of social, economic and environmental development issues. The first-place business is awarded a $100,000 grant, second place receives $60,000 and third place gets $30,000. Winners also receive executive coaching and the opportunity to participate in a variety of training workshops.

Businesses in Tampa, Florida can apply for the CRA Commercial grant to improve their properties, including performing internal or external expansions and renovations. To qualify for one of these grants, your business must be located in a designated CRA area. To apply for one of these Florida business grants, you must schedule a pre-application meeting with CRA staff. You can request an appointment by calling the Tampa CRA or submitting an online request.

This grant supports early-stage socio-technical partnerships focused on research data infrastructure ecosystems. The Cyberinfrastructure for Public Access and Open Science (CI PAOS) program within the Office of Advanced Cyberinfrastructure (OAC) aims to catalyze new and transformative socio-technical partnerships supporting research data infrastructure ecosystems across domains through early-stage collaborative activities between cyberinfrastructure researchers, scientists, research computing experts, data management experts, research labs, university libraries, and other communities of practice. The CI PAOS program supports the NSF Public Access Initiative by encouraging innovation across the CI ecosystem to address accessibility, discoverability, reliability, reproducibility, sustainability, and utility of data products in alignment with NSF and national goals for public access and open science. NSF accepts proposals pursuant to this Program Description year-round. From time to time, NSF may also issue Dear Colleague Letters to encourage proposals on special thematic interests and opportunities related to this program.

The Rhode Island Lift Program is a strategic investment initiative designed to fuel the growth and successful capital raise of high-impact life sciences companies in Rhode Island. This competitive program provides a non-dilutive funding boost to companies that have finalized or recently closed a funding round. By offering this last infusion of capital, the program helps high-potential life sciences ventures scale their operations, drive innovation, and strengthen their impact on the state’s economy, industry growth, and patient outcomes. Through this support, Rhode Island continues to position itself as a leader in life sciences advancement and commercialization.